These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 17124496)

  • 21. Tumor necrosis factor-like weak inducer of apoptosis association with proliferative diabetic retinopathy and promotes proliferation and collagen synthesis in retinal ARPE-19 cells.
    Chen DY; Su GF
    Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27050952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TWEAK favors phosphate-induced calcification of vascular smooth muscle cells through canonical and non-canonical activation of NFκB.
    Hénaut L; Sanz AB; Martin-Sanchez D; Carrasco S; Villa-Bellosta R; Aldamiz-Echevarria G; Massy ZA; Sanchez-Nino MD; Ortiz A
    Cell Death Dis; 2016 Jul; 7(7):e2305. PubMed ID: 27441657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of TWEAK with Fn14 leads to the progression of fibrotic liver disease by directly modulating hepatic stellate cell proliferation.
    Wilhelm A; Shepherd EL; Amatucci A; Munir M; Reynolds G; Humphreys E; Resheq Y; Adams DH; Hübscher S; Burkly LC; Weston CJ; Afford SC
    J Pathol; 2016 May; 239(1):109-21. PubMed ID: 26924336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fn14 in podocytes and proteinuric kidney disease.
    Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
    Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice.
    Mittal A; Bhatnagar S; Kumar A; Lach-Trifilieff E; Wauters S; Li H; Makonchuk DY; Glass DJ; Kumar A
    J Cell Biol; 2010 Mar; 188(6):833-49. PubMed ID: 20308426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TWEAK and TRAF6 regulate skeletal muscle atrophy.
    Kumar A; Bhatnagar S; Paul PK
    Curr Opin Clin Nutr Metab Care; 2012 May; 15(3):233-9. PubMed ID: 22366923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue. Relationship with other inflammatory cytokines in obesity.
    Chacón MR; Richart C; Gómez JM; Megía A; Vilarrasa N; Fernández-Real JM; García-España A; Miranda M; Masdevall C; Ricard W; Caubet E; Soler J; Vendrell J
    Cytokine; 2006 Feb; 33(3):129-37. PubMed ID: 16503147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor necrosis factor-like weak inducer of apoptosis or Fn14 deficiency reduce elastase perfusion-induced aortic abdominal aneurysm in mice.
    Tarín C; Fernández-Laso V; Sastre C; Madrigal-Matute J; Gómez M; Zaragoza C; Egido J; Burkly LC; Martín-Ventura JL; Blanco-Colio LM
    J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25092786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TWEAK/Fn14 promotes apoptosis of human endometrial cancer cells via caspase pathway.
    Wang D; Fung JN; Tuo Y; Hu L; Chen C
    Cancer Lett; 2010 Aug; 294(1):91-100. PubMed ID: 20189297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TWEAK/Fn14 axis: the current paradigm of tissue injury-inducible function in the midst of complexities.
    Burkly LC
    Semin Immunol; 2014 Jun; 26(3):229-36. PubMed ID: 24636536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The TWEAK-Fn14 system: breaking the silence of cytokine-induced skeletal muscle wasting.
    Bhatnagar S; Kumar A
    Curr Mol Med; 2012 Jan; 12(1):3-13. PubMed ID: 22082477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TWEAK/Fn14 activation induces keratinocyte proliferation under psoriatic inflammation.
    Cheng H; Xu M; Liu X; Zou X; Zhan N; Xia Y
    Exp Dermatol; 2016 Jan; 25(1):32-7. PubMed ID: 26264384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesenchymal stem cells and myoblast differentiation under HGF and IGF-1 stimulation for 3D skeletal muscle tissue engineering.
    Witt R; Weigand A; Boos AM; Cai A; Dippold D; Boccaccini AR; Schubert DW; Hardt M; Lange C; Arkudas A; Horch RE; Beier JP
    BMC Cell Biol; 2017 Feb; 18(1):15. PubMed ID: 28245809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TWEAK-Fn14 pathway activation after exercise in human skeletal muscle: insights from two exercise modes and a time course investigation.
    Raue U; Jemiolo B; Yang Y; Trappe S
    J Appl Physiol (1985); 2015 Mar; 118(5):569-78. PubMed ID: 25539934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells.
    Roos A; Dhruv HD; Mathews IT; Inge LJ; Tuncali S; Hartman LK; Chow D; Millard N; Yin HH; Kloss J; Loftus JC; Winkles JA; Berens ME; Tran NL
    Oncotarget; 2017 Feb; 8(7):12234-12246. PubMed ID: 28103571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice.
    Meijboom KE; Sutton ER; McCallion E; McFall E; Anthony D; Edwards B; Kubinski S; Tapken I; Bünermann I; Hazell G; Ahlskog N; Claus P; Davies KE; Kothary R; Wood MJA; Bowerman M
    Skelet Muscle; 2022 Jul; 12(1):18. PubMed ID: 35902978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of TWEAK/Fn14 in neuroblastoma: implications in tumorigenesis.
    Pettersen I; Baryawno N; Abel F; Bakkelund WH; Zykova SN; Winberg JO; Moens U; Rasmuson A; Kogner P; Johnsen JI; Sveinbjörnsson B
    Int J Oncol; 2013 Apr; 42(4):1239-48. PubMed ID: 23443741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA.
    Kamijo S; Nakajima A; Kamata K; Kurosawa H; Yagita H; Okumura K
    Rheumatology (Oxford); 2008 Apr; 47(4):442-50. PubMed ID: 18310134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Considering TWEAK as a target for therapy in renal and vascular injury.
    Ortiz A; Sanz AB; Muñoz García B; Moreno JA; Sánchez Niño MD; Martín-Ventura JL; Egido J; Blanco-Colio LM
    Cytokine Growth Factor Rev; 2009 Jun; 20(3):251-8. PubMed ID: 19482507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TWEAK is a positive regulator of cardiomyocyte proliferation.
    Novoyatleva T; Diehl F; van Amerongen MJ; Patra C; Ferrazzi F; Bellazzi R; Engel FB
    Cardiovasc Res; 2010 Mar; 85(4):681-90. PubMed ID: 19887380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.